CZ20021974A3 - Substituované ftalocyaniny, způsob jejich výroby a farmaceutický prostředek obsahující tyto sloučeniny - Google Patents
Substituované ftalocyaniny, způsob jejich výroby a farmaceutický prostředek obsahující tyto sloučeniny Download PDFInfo
- Publication number
- CZ20021974A3 CZ20021974A3 CZ20021974A CZ20021974A CZ20021974A3 CZ 20021974 A3 CZ20021974 A3 CZ 20021974A3 CZ 20021974 A CZ20021974 A CZ 20021974A CZ 20021974 A CZ20021974 A CZ 20021974A CZ 20021974 A3 CZ20021974 A3 CZ 20021974A3
- Authority
- CZ
- Czechia
- Prior art keywords
- group
- optionally substituted
- formula
- carbon atoms
- substituted
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims abstract description 108
- 230000008569 process Effects 0.000 title claims abstract description 39
- 150000001875 compounds Chemical class 0.000 title description 72
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- -1 phthalonitrile sulfonate esters Chemical class 0.000 claims abstract description 206
- 229920006391 phthalonitrile polymer Polymers 0.000 claims abstract description 162
- 125000004432 carbon atom Chemical group C* 0.000 claims description 195
- 125000001424 substituent group Chemical group 0.000 claims description 127
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 124
- 238000006243 chemical reaction Methods 0.000 claims description 103
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 101
- 125000000217 alkyl group Chemical group 0.000 claims description 100
- XQZYPMVTSDWCCE-UHFFFAOYSA-N phthalonitrile Chemical class N#CC1=CC=CC=C1C#N XQZYPMVTSDWCCE-UHFFFAOYSA-N 0.000 claims description 95
- 125000001153 fluoro group Chemical group F* 0.000 claims description 80
- 125000003342 alkenyl group Chemical group 0.000 claims description 77
- 239000011701 zinc Substances 0.000 claims description 76
- 229910052725 zinc Inorganic materials 0.000 claims description 73
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 64
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 60
- 229910052801 chlorine Inorganic materials 0.000 claims description 57
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 51
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 49
- 229910052731 fluorine Inorganic materials 0.000 claims description 48
- 125000003118 aryl group Chemical group 0.000 claims description 44
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 44
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 42
- 229910052794 bromium Inorganic materials 0.000 claims description 42
- 125000001072 heteroaryl group Chemical group 0.000 claims description 42
- 239000000460 chlorine Substances 0.000 claims description 41
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 40
- 229910052763 palladium Inorganic materials 0.000 claims description 40
- 229910052740 iodine Inorganic materials 0.000 claims description 36
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 35
- 239000003153 chemical reaction reagent Substances 0.000 claims description 32
- 230000005855 radiation Effects 0.000 claims description 31
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 30
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 28
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 27
- 239000011737 fluorine Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 125000000304 alkynyl group Chemical group 0.000 claims description 25
- 125000001246 bromo group Chemical group Br* 0.000 claims description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims description 23
- 125000003107 substituted aryl group Chemical group 0.000 claims description 23
- 239000001257 hydrogen Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 19
- 229920006395 saturated elastomer Polymers 0.000 claims description 19
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 19
- 125000004426 substituted alkynyl group Chemical group 0.000 claims description 19
- 206010028980 Neoplasm Diseases 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 18
- 239000002184 metal Substances 0.000 claims description 18
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 18
- 229910052710 silicon Inorganic materials 0.000 claims description 18
- 239000010703 silicon Substances 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 17
- 229910052759 nickel Inorganic materials 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 16
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000002428 photodynamic therapy Methods 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 150000004820 halides Chemical class 0.000 claims description 14
- 239000011777 magnesium Substances 0.000 claims description 14
- 229910052749 magnesium Inorganic materials 0.000 claims description 13
- 229920001184 polypeptide Polymers 0.000 claims description 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- MPAIWVOBMLSHQA-UHFFFAOYSA-N 3,6-dihydroxybenzene-1,2-dicarbonitrile Chemical class OC1=CC=C(O)C(C#N)=C1C#N MPAIWVOBMLSHQA-UHFFFAOYSA-N 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Chemical group 0.000 claims description 12
- 229930195729 fatty acid Chemical group 0.000 claims description 12
- 150000004665 fatty acids Chemical group 0.000 claims description 12
- 150000004676 glycans Chemical class 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 150000007523 nucleic acids Chemical group 0.000 claims description 12
- 108020004707 nucleic acids Chemical group 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 229920001282 polysaccharide Polymers 0.000 claims description 12
- 239000005017 polysaccharide Substances 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 229910052782 aluminium Inorganic materials 0.000 claims description 10
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 10
- 125000004429 atom Chemical group 0.000 claims description 10
- 125000002346 iodo group Chemical group I* 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- 229910052697 platinum Inorganic materials 0.000 claims description 9
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 8
- 238000006555 catalytic reaction Methods 0.000 claims description 8
- 206010020718 hyperplasia Diseases 0.000 claims description 8
- 208000031295 Animal disease Diseases 0.000 claims description 7
- 229910001509 metal bromide Inorganic materials 0.000 claims description 7
- 229910044991 metal oxide Inorganic materials 0.000 claims description 7
- 150000004706 metal oxides Chemical class 0.000 claims description 7
- 230000002792 vascular Effects 0.000 claims description 7
- 229910052796 boron Inorganic materials 0.000 claims description 6
- 230000004663 cell proliferation Effects 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 229910001510 metal chloride Inorganic materials 0.000 claims description 6
- 201000004624 Dermatitis Diseases 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
- 201000004681 Psoriasis Diseases 0.000 claims description 5
- 238000005804 alkylation reaction Methods 0.000 claims description 5
- 208000010668 atopic eczema Diseases 0.000 claims description 5
- 238000006880 cross-coupling reaction Methods 0.000 claims description 5
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 5
- 239000012038 nucleophile Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims description 4
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 4
- 208000031220 Hemophilia Diseases 0.000 claims description 4
- 208000009292 Hemophilia A Diseases 0.000 claims description 4
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 4
- 208000001126 Keratosis Diseases 0.000 claims description 4
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 4
- 206010057469 Vascular stenosis Diseases 0.000 claims description 4
- 230000029936 alkylation Effects 0.000 claims description 4
- 206010003246 arthritis Diseases 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 230000002538 fungal effect Effects 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 230000002757 inflammatory effect Effects 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 230000003211 malignant effect Effects 0.000 claims description 4
- 201000008482 osteoarthritis Diseases 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 108091000054 Prion Proteins 0.000 claims description 3
- 102000029797 Prion Human genes 0.000 claims description 3
- 230000002152 alkylating effect Effects 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 2
- 201000005962 mycosis fungoides Diseases 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 447
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 327
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 229
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 182
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 166
- 239000000203 mixture Substances 0.000 description 152
- 239000000243 solution Substances 0.000 description 148
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 111
- 238000005481 NMR spectroscopy Methods 0.000 description 101
- 239000011541 reaction mixture Substances 0.000 description 93
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 90
- 239000000047 product Substances 0.000 description 84
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 81
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 70
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 69
- 239000003208 petroleum Substances 0.000 description 64
- 239000002904 solvent Substances 0.000 description 62
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 61
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 60
- 239000007787 solid Substances 0.000 description 56
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 50
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- 238000010992 reflux Methods 0.000 description 46
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 46
- 238000009835 boiling Methods 0.000 description 45
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 44
- 238000007792 addition Methods 0.000 description 43
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 40
- DSZGQEHPKNNPFU-UHFFFAOYSA-N 3,6-didecylbenzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCC1=CC=C(CCCCCCCCCC)C(C#N)=C1C#N DSZGQEHPKNNPFU-UHFFFAOYSA-N 0.000 description 37
- 238000010898 silica gel chromatography Methods 0.000 description 37
- 239000002585 base Substances 0.000 description 36
- 229910052757 nitrogen Inorganic materials 0.000 description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 238000001816 cooling Methods 0.000 description 33
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- 239000012267 brine Substances 0.000 description 30
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 25
- 239000003054 catalyst Substances 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 22
- 229910052786 argon Inorganic materials 0.000 description 22
- 230000000875 corresponding effect Effects 0.000 description 22
- 239000003480 eluent Substances 0.000 description 22
- 238000001704 evaporation Methods 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 21
- 238000004440 column chromatography Methods 0.000 description 21
- 230000008020 evaporation Effects 0.000 description 21
- 230000002093 peripheral effect Effects 0.000 description 20
- AYGKNJJGSMKDPA-UHFFFAOYSA-N 4-bromo-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC(Br)=C(OCCCC)C(C#N)=C1C#N AYGKNJJGSMKDPA-UHFFFAOYSA-N 0.000 description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 19
- 239000000741 silica gel Substances 0.000 description 19
- 229910002027 silica gel Inorganic materials 0.000 description 19
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 18
- 239000012043 crude product Substances 0.000 description 18
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 17
- YZYKBQUWMPUVEN-UHFFFAOYSA-N zafuleptine Chemical compound OC(=O)CCCCCC(C(C)C)NCC1=CC=C(F)C=C1 YZYKBQUWMPUVEN-UHFFFAOYSA-N 0.000 description 17
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 16
- 239000013078 crystal Substances 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 15
- 238000006467 substitution reaction Methods 0.000 description 15
- 238000004809 thin layer chromatography Methods 0.000 description 15
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo(3.3.1)nonane Chemical compound C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 14
- FCAPKPPCJBYHEC-UHFFFAOYSA-N [2,3-dicyano-4-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(OS(=O)(=O)C(F)(F)F)C(C#N)=C1C#N FCAPKPPCJBYHEC-UHFFFAOYSA-N 0.000 description 14
- 238000001914 filtration Methods 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- 238000001953 recrystallisation Methods 0.000 description 13
- 239000000725 suspension Substances 0.000 description 13
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 13
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 12
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 12
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 12
- 230000000155 isotopic effect Effects 0.000 description 12
- 229910052744 lithium Inorganic materials 0.000 description 12
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 12
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 12
- HAAHMAILBWIUSO-UHFFFAOYSA-N 4,5-dibromo-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound CCCCOC1=C(Br)C(Br)=C(OCCCC)C(C#N)=C1C#N HAAHMAILBWIUSO-UHFFFAOYSA-N 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 11
- 239000002274 desiccant Substances 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- FDGUZCMQOHCDOY-UHFFFAOYSA-M [I-].CCCCCCCCCC[Zn+] Chemical compound [I-].CCCCCCCCCC[Zn+] FDGUZCMQOHCDOY-UHFFFAOYSA-M 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 10
- 235000014633 carbohydrates Nutrition 0.000 description 10
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 10
- 239000012300 argon atmosphere Substances 0.000 description 9
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 9
- 125000000524 functional group Chemical group 0.000 description 9
- 150000002431 hydrogen Chemical class 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- 229910052720 vanadium Inorganic materials 0.000 description 9
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 8
- 230000005670 electromagnetic radiation Effects 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000003504 photosensitizing agent Substances 0.000 description 8
- 238000007363 ring formation reaction Methods 0.000 description 8
- PUFIXALSROVACG-UHFFFAOYSA-N 4,5-dibromo-3,6-dihydroxybenzene-1,2-dicarbonitrile Chemical compound OC1=C(Br)C(Br)=C(O)C(C#N)=C1C#N PUFIXALSROVACG-UHFFFAOYSA-N 0.000 description 7
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 7
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- 239000002502 liposome Substances 0.000 description 7
- ZBRJXVVKPBZPAN-UHFFFAOYSA-L nickel(2+);triphenylphosphane;dichloride Chemical compound [Cl-].[Cl-].[Ni+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 ZBRJXVVKPBZPAN-UHFFFAOYSA-L 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 7
- 239000011592 zinc chloride Substances 0.000 description 7
- 235000005074 zinc chloride Nutrition 0.000 description 7
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 description 6
- 150000001336 alkenes Chemical class 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000010408 film Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 239000004246 zinc acetate Substances 0.000 description 6
- KYPOHTVBFVELTG-OWOJBTEDSA-N (e)-but-2-enedinitrile Chemical compound N#C\C=C\C#N KYPOHTVBFVELTG-OWOJBTEDSA-N 0.000 description 5
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 5
- NTJBPRBBLQKOTL-UHFFFAOYSA-N 3,6-dibutoxy-4-[4-(hydroxymethyl)phenyl]benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(CO)=CC=2)=C1OCCCC NTJBPRBBLQKOTL-UHFFFAOYSA-N 0.000 description 5
- SKTSZLTUDJZCEX-UHFFFAOYSA-N 3,6-diphenylbenzene-1,2-dicarbonitrile Chemical compound N#CC=1C(C#N)=C(C=2C=CC=CC=2)C=CC=1C1=CC=CC=C1 SKTSZLTUDJZCEX-UHFFFAOYSA-N 0.000 description 5
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 5
- 101150003085 Pdcl gene Proteins 0.000 description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
- 229910000024 caesium carbonate Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 5
- 239000001301 oxygen Chemical group 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 229910052718 tin Inorganic materials 0.000 description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 5
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 4
- SKIDNYUZJPMKFC-UHFFFAOYSA-N 1-iododecane Chemical compound CCCCCCCCCCI SKIDNYUZJPMKFC-UHFFFAOYSA-N 0.000 description 4
- ZWDXFPRCFLWNBO-UHFFFAOYSA-N 3,6-bis(4-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound C1=CC(OC)=CC=C1C(C(=C1C#N)C#N)=CC=C1C1=CC=C(OC)C=C1 ZWDXFPRCFLWNBO-UHFFFAOYSA-N 0.000 description 4
- PXLFZVNSJRPRPT-UHFFFAOYSA-N 3,6-bis(6-imidazol-1-ylhexyl)benzene-1,2-dicarbonitrile Chemical compound C1=CC(CCCCCCN2C=NC=C2)=C(C#N)C(C#N)=C1CCCCCCN1C=CN=C1 PXLFZVNSJRPRPT-UHFFFAOYSA-N 0.000 description 4
- PKUNOLIHEQYMCI-UHFFFAOYSA-N 3,6-bis(dodecylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCCCSC1=CC=C(SCCCCCCCCCCCC)C(C#N)=C1C#N PKUNOLIHEQYMCI-UHFFFAOYSA-N 0.000 description 4
- UUMCRBQWJBUMCW-UHFFFAOYSA-N 3,6-bis(hexylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCSC1=CC=C(SCCCCCC)C(C#N)=C1C#N UUMCRBQWJBUMCW-UHFFFAOYSA-N 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000001502 aryl halides Chemical class 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000005292 diamagnetic effect Effects 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 238000012746 preparative thin layer chromatography Methods 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000010626 work up procedure Methods 0.000 description 4
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 4
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 3
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 3
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 3
- DRLUTAGZMJJXGQ-UHFFFAOYSA-N 3,6-bis(3-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound COC1=CC=CC(C=2C(=C(C#N)C(C=3C=C(OC)C=CC=3)=CC=2)C#N)=C1 DRLUTAGZMJJXGQ-UHFFFAOYSA-N 0.000 description 3
- BMYRXJQPTUJNCF-UHFFFAOYSA-N 3,6-bis(4-chlorobutyl)benzene-1,2-dicarbonitrile Chemical compound ClCCCCC1=CC=C(CCCCCl)C(C#N)=C1C#N BMYRXJQPTUJNCF-UHFFFAOYSA-N 0.000 description 3
- PUUJFDXHWZXBLV-UHFFFAOYSA-N 3,6-bis(6-chlorohexyl)benzene-1,2-dicarbonitrile Chemical compound ClCCCCCCC1=CC=C(CCCCCCCl)C(C#N)=C1C#N PUUJFDXHWZXBLV-UHFFFAOYSA-N 0.000 description 3
- HLWHEMMJDQNAPJ-UHFFFAOYSA-N 3,6-bis(decylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCSC1=CC=C(SCCCCCCCCCC)C(C#N)=C1C#N HLWHEMMJDQNAPJ-UHFFFAOYSA-N 0.000 description 3
- GLTAPYYPPPWROQ-UHFFFAOYSA-N 3,6-dibutoxy-4,5-diphenylbenzene-1,2-dicarbonitrile Chemical compound C=1C=CC=CC=1C=1C(OCCCC)=C(C#N)C(C#N)=C(OCCCC)C=1C1=CC=CC=C1 GLTAPYYPPPWROQ-UHFFFAOYSA-N 0.000 description 3
- ZLPCKQYOZCZIKL-UHFFFAOYSA-N 3,6-dibutoxy-4-phenylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC=CC=2)=C1OCCCC ZLPCKQYOZCZIKL-UHFFFAOYSA-N 0.000 description 3
- CMWOPHRVYNICBF-UHFFFAOYSA-N 3,6-dibutoxy-4-thiophen-2-ylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2SC=CC=2)=C1OCCCC CMWOPHRVYNICBF-UHFFFAOYSA-N 0.000 description 3
- KGYBWMZQDGCJSE-UHFFFAOYSA-N 4-(4-aminophenyl)-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(N)=CC=2)=C1OCCCC KGYBWMZQDGCJSE-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 3
- 101000738322 Homo sapiens Prothymosin alpha Proteins 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 description 3
- 102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 3
- VQFXQNFXFGACHE-UHFFFAOYSA-N [4-(2,5-dibutoxy-3,4-dicyanophenyl)phenyl]methyl methanesulfonate Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(COS(C)(=O)=O)=CC=2)=C1OCCCC VQFXQNFXFGACHE-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 3
- XJHCXCQVJFPJIK-UHFFFAOYSA-M cesium fluoride Substances [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 3
- 229910052733 gallium Inorganic materials 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 229910052738 indium Inorganic materials 0.000 description 3
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 3
- 229910052747 lanthanoid Inorganic materials 0.000 description 3
- 150000002602 lanthanoids Chemical class 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000011133 lead Substances 0.000 description 3
- LTRVAZKHJRYLRJ-UHFFFAOYSA-N lithium;butan-1-olate Chemical compound [Li+].CCCC[O-] LTRVAZKHJRYLRJ-UHFFFAOYSA-N 0.000 description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000010955 niobium Substances 0.000 description 3
- 229910052758 niobium Inorganic materials 0.000 description 3
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 230000000886 photobiology Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
- 239000011135 tin Substances 0.000 description 3
- UYMSTSQPXWFMFR-UHFFFAOYSA-N tridecylborane Chemical compound BCCCCCCCCCCCCC UYMSTSQPXWFMFR-UHFFFAOYSA-N 0.000 description 3
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical compound C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 3
- XPARCVGSTPKNNR-UHFFFAOYSA-M zinc;ethyl butanoate;bromide Chemical compound [Zn+2].[Br-].CCOC(=O)CC[CH2-] XPARCVGSTPKNNR-UHFFFAOYSA-M 0.000 description 3
- YHHYDZPBBOPWLN-UHFFFAOYSA-N (2,3-dicyanophenyl) trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=CC(C#N)=C1C#N YHHYDZPBBOPWLN-UHFFFAOYSA-N 0.000 description 2
- FIRODXFCQOQZSE-UHFFFAOYSA-N (8-bromoquinolin-4-yl)methanol Chemical compound C1=CC=C2C(CO)=CC=NC2=C1Br FIRODXFCQOQZSE-UHFFFAOYSA-N 0.000 description 2
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 description 2
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 2
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- VBWZXZKZQWHCOM-UHFFFAOYSA-N 2,5-dibutoxy-4-(2,3-dicyanophenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(OCCCC)=CC(C=2C(=C(C#N)C=CC=2)C#N)=C1OCCCC VBWZXZKZQWHCOM-UHFFFAOYSA-N 0.000 description 2
- XGLVDUUYFKXKPL-UHFFFAOYSA-N 2-(2-methoxyethoxy)-n,n-bis[2-(2-methoxyethoxy)ethyl]ethanamine Chemical compound COCCOCCN(CCOCCOC)CCOCCOC XGLVDUUYFKXKPL-UHFFFAOYSA-N 0.000 description 2
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 2
- HELXNKJXGBWXDN-UHFFFAOYSA-N 3,6-bis[4-[tert-butyl(dimethyl)silyl]oxybutyl]benzene-1,2-dicarbonitrile Chemical compound CC(C)(C)[Si](C)(C)OCCCCC1=CC=C(CCCCO[Si](C)(C)C(C)(C)C)C(C#N)=C1C#N HELXNKJXGBWXDN-UHFFFAOYSA-N 0.000 description 2
- VIWINWVCKDNVIZ-UHFFFAOYSA-N 3,6-di(piperidin-1-yl)benzene-1,2-dicarbonitrile Chemical compound N#CC=1C(C#N)=C(N2CCCCC2)C=CC=1N1CCCCC1 VIWINWVCKDNVIZ-UHFFFAOYSA-N 0.000 description 2
- GXFSEGQRWQOYFV-UHFFFAOYSA-N 3,6-dibutoxy-4-(4-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(OC)=CC=2)=C1OCCCC GXFSEGQRWQOYFV-UHFFFAOYSA-N 0.000 description 2
- IIBMGBRQXLEZPD-UHFFFAOYSA-N 3,6-dibutoxy-4-[4-(dimethylamino)phenyl]benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(=CC=2)N(C)C)=C1OCCCC IIBMGBRQXLEZPD-UHFFFAOYSA-N 0.000 description 2
- DNIMPKVOFJESNJ-UHFFFAOYSA-N 3,6-dibutoxy-4-pyridin-4-ylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CN=CC=2)=C1OCCCC DNIMPKVOFJESNJ-UHFFFAOYSA-N 0.000 description 2
- RJFAMAFEWDBSLX-UHFFFAOYSA-N 3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC=C(OCCCC)C(C#N)=C1C#N RJFAMAFEWDBSLX-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- FAOJEIKFLZQLBH-UHFFFAOYSA-N 7-iodo-2,2-dimethylheptan-3-one Chemical compound CC(C)(C)C(=O)CCCCI FAOJEIKFLZQLBH-UHFFFAOYSA-N 0.000 description 2
- 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 238000007341 Heck reaction Methods 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 238000006411 Negishi coupling reaction Methods 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- JKCYUAPVJLZDCT-UHFFFAOYSA-N [2,3-dicyano-4-(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyloxy)phenyl] 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(=O)(=O)OC1=CC=C(OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(C#N)=C1C#N JKCYUAPVJLZDCT-UHFFFAOYSA-N 0.000 description 2
- PAVFOQDYFGUYPY-UHFFFAOYSA-M [Br-].ClCCCCCC[Zn+] Chemical compound [Br-].ClCCCCCC[Zn+] PAVFOQDYFGUYPY-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 150000001356 alkyl thiols Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 150000001499 aryl bromides Chemical class 0.000 description 2
- 150000001500 aryl chlorides Chemical class 0.000 description 2
- 150000001503 aryl iodides Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910000085 borane Inorganic materials 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 125000004122 cyclic group Chemical class 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 239000002254 cytotoxic agent Substances 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- VTXVGVNLYGSIAR-UHFFFAOYSA-N decane-1-thiol Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- YWFGJRGXFPIQDZ-UHFFFAOYSA-N ethyl 4-(2,5-dibutoxy-3,4-dicyanophenyl)butanoate Chemical compound CCCCOC1=CC(CCCC(=O)OCC)=C(OCCCC)C(C#N)=C1C#N YWFGJRGXFPIQDZ-UHFFFAOYSA-N 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 208000024386 fungal infectious disease Diseases 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- APHGZSBLRQFRCA-UHFFFAOYSA-M indium(1+);chloride Chemical compound [In]Cl APHGZSBLRQFRCA-UHFFFAOYSA-M 0.000 description 2
- PSCMQHVBLHHWTO-UHFFFAOYSA-K indium(iii) chloride Chemical compound Cl[In](Cl)Cl PSCMQHVBLHHWTO-UHFFFAOYSA-K 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229940046892 lead acetate Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000005649 metathesis reaction Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- BMGNSKKZFQMGDH-FDGPNNRMSA-L nickel(2+);(z)-4-oxopent-2-en-2-olate Chemical compound [Ni+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O BMGNSKKZFQMGDH-FDGPNNRMSA-L 0.000 description 2
- HIIGGQNLPWIVAG-UHFFFAOYSA-L nickel(2+);diacetate;hydrate Chemical compound O.[Ni+2].CC([O-])=O.CC([O-])=O HIIGGQNLPWIVAG-UHFFFAOYSA-L 0.000 description 2
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 150000002940 palladium Chemical class 0.000 description 2
- 238000010651 palladium-catalyzed cross coupling reaction Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 description 2
- 208000017983 photosensitivity disease Diseases 0.000 description 2
- 231100000434 photosensitization Toxicity 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- 108010031345 placental alkaline phosphatase Proteins 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 229910052717 sulfur Chemical group 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 2
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- 229940102001 zinc bromide Drugs 0.000 description 2
- XRILZZJFFXPAEL-UHFFFAOYSA-N (2,3-dicyano-4-decylphenyl) trifluoromethanesulfonate Chemical compound CCCCCCCCCCC1=CC=C(OS(=O)(=O)C(F)(F)F)C(C#N)=C1C#N XRILZZJFFXPAEL-UHFFFAOYSA-N 0.000 description 1
- MKPDAJWEBQRQCO-UHFFFAOYSA-N (4-aminophenyl)boronic acid Chemical compound NC1=CC=C(B(O)O)C=C1 MKPDAJWEBQRQCO-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-BJUDXGSMSA-N (6Li)Lithium Chemical compound [6Li] WHXSMMKQMYFTQS-BJUDXGSMSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YYOGYQNNOGKIFI-UHFFFAOYSA-N 1,4-bis(3-methoxyphenyl)cyclohexa-3,5-diene-1,2-dicarbonitrile Chemical compound COC1=CC=CC(C=2C=CC(C(C#N)C=2)(C#N)C=2C=C(OC)C=CC=2)=C1 YYOGYQNNOGKIFI-UHFFFAOYSA-N 0.000 description 1
- JJBQXTABLSZHGC-UHFFFAOYSA-N 1,4-dihydroxynaphthalene-2,3-dicarbonitrile Chemical compound C1=CC=C2C(O)=C(C#N)C(C#N)=C(O)C2=C1 JJBQXTABLSZHGC-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- PYEQXZOIQJWYAH-UHFFFAOYSA-N 2-bromocyclohexa-2,5-diene-1,4-dione Chemical compound BrC1=CC(=O)C=CC1=O PYEQXZOIQJWYAH-UHFFFAOYSA-N 0.000 description 1
- CCZWSTFVHJPCEM-UHFFFAOYSA-N 2-iodopyridine Chemical compound IC1=CC=CC=N1 CCZWSTFVHJPCEM-UHFFFAOYSA-N 0.000 description 1
- CEBKHWWANWSNTI-UHFFFAOYSA-N 2-methylbut-3-yn-2-ol Chemical compound CC(C)(O)C#C CEBKHWWANWSNTI-UHFFFAOYSA-N 0.000 description 1
- CFIYISMWOOTOLG-UHFFFAOYSA-N 3,6-bis(6,6-dimethyl-5-oxoheptyl)benzene-1,2-dicarbonitrile Chemical compound CC(C)(C)C(=O)CCCCC1=CC=C(CCCCC(=O)C(C)(C)C)C(C#N)=C1C#N CFIYISMWOOTOLG-UHFFFAOYSA-N 0.000 description 1
- GOPNQBNDBLKOGZ-UHFFFAOYSA-N 3,6-bis(heptylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCSC1=CC=C(SCCCCCCC)C(C#N)=C1C#N GOPNQBNDBLKOGZ-UHFFFAOYSA-N 0.000 description 1
- VMNBVZXPKRYDHE-UHFFFAOYSA-N 3,6-bis(nonylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCSC1=CC=C(SCCCCCCCCC)C(C#N)=C1C#N VMNBVZXPKRYDHE-UHFFFAOYSA-N 0.000 description 1
- YPFCPDDBDOIGHD-UHFFFAOYSA-N 3,6-bis(octylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCSC1=CC=C(SCCCCCCCC)C(C#N)=C1C#N YPFCPDDBDOIGHD-UHFFFAOYSA-N 0.000 description 1
- ZEPIONWMIXGQDP-UHFFFAOYSA-N 3,6-bis(undecylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCCSC1=CC=C(SCCCCCCCCCCC)C(C#N)=C1C#N ZEPIONWMIXGQDP-UHFFFAOYSA-N 0.000 description 1
- APUOFYQGISEQAA-UHFFFAOYSA-N 3,6-dibutoxy-4-(4-oxohexyl)benzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC(CCCC(=O)CC)=C(OCCCC)C(C#N)=C1C#N APUOFYQGISEQAA-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- SWBMSIBEMDFILF-UHFFFAOYSA-N 3-butan-2-yloxybenzene-1,2-dicarbonitrile Chemical compound CCC(C)OC1=CC=CC(C#N)=C1C#N SWBMSIBEMDFILF-UHFFFAOYSA-N 0.000 description 1
- OYPIAMMBWHEBHP-UHFFFAOYSA-N 4-(2,5-dibutoxy-3,4-dicyanophenyl)benzoic acid Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(=CC=2)C(O)=O)=C1OCCCC OYPIAMMBWHEBHP-UHFFFAOYSA-N 0.000 description 1
- NLTIETZTDSJANS-UHFFFAOYSA-N 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=NC=C1 NLTIETZTDSJANS-UHFFFAOYSA-N 0.000 description 1
- DFKKJQABUJCNLE-UHFFFAOYSA-N 4-(hydrazinylmethyl)phenol Chemical compound NNCC1=CC=C(O)C=C1 DFKKJQABUJCNLE-UHFFFAOYSA-N 0.000 description 1
- XEUXQSZILBIIEJ-UHFFFAOYSA-N 4-[2,3-dicyano-4-[4-(2,2-dimethylpropanoyloxy)butyl]phenyl]butyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCCCC1=CC=C(CCCCOC(=O)C(C)(C)C)C(C#N)=C1C#N XEUXQSZILBIIEJ-UHFFFAOYSA-N 0.000 description 1
- SIAVMDKGVRXFAX-UHFFFAOYSA-N 4-carboxyphenylboronic acid Chemical compound OB(O)C1=CC=C(C(O)=O)C=C1 SIAVMDKGVRXFAX-UHFFFAOYSA-N 0.000 description 1
- RTLUPHDWSUGAOS-UHFFFAOYSA-N 4-iodopyridine Chemical compound IC1=CC=NC=C1 RTLUPHDWSUGAOS-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 101100129007 Arabidopsis thaliana LTD gene Proteins 0.000 description 1
- 241001120493 Arene Species 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- HEPSLFGQJSHKLJ-UHFFFAOYSA-N C(CCCCCCCCC)C1=C(C(C#N)=CC(=C1)CCCCCCCCCC)C#N Chemical compound C(CCCCCCCCC)C1=C(C(C#N)=CC(=C1)CCCCCCCCCC)C#N HEPSLFGQJSHKLJ-UHFFFAOYSA-N 0.000 description 1
- JAZGGNIVSIGGBU-UHFFFAOYSA-N C(CCCCCCCCC)C1=C(C(C#N)=CC=C1)C#N Chemical compound C(CCCCCCCCC)C1=C(C(C#N)=CC=C1)C#N JAZGGNIVSIGGBU-UHFFFAOYSA-N 0.000 description 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 description 1
- 125000006416 CBr Chemical group BrC* 0.000 description 1
- QAEGJXBKLGGWKA-UHFFFAOYSA-N CC(C)(C)[Si](C)(C)OCCCCc1cccc(C#N)c1C#N Chemical compound CC(C)(C)[Si](C)(C)OCCCCc1cccc(C#N)c1C#N QAEGJXBKLGGWKA-UHFFFAOYSA-N 0.000 description 1
- PBEHMIMZBVHCBF-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC[Zn] Chemical compound CCCCCCCCCCCCCCCCCC[Zn] PBEHMIMZBVHCBF-UHFFFAOYSA-N 0.000 description 1
- 241000819038 Chichester Species 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 241001050985 Disco Species 0.000 description 1
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 229910021617 Indium monochloride Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- 101100505385 Mus musculus Gpd1 gene Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- GOTYPHJYOIRENG-QRPNPIFTSA-N OBO.OC(=O)[C@@H](N)CC1=CC=CC=C1 Chemical class OBO.OC(=O)[C@@H](N)CC1=CC=CC=C1 GOTYPHJYOIRENG-QRPNPIFTSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229910004219 SiNi Inorganic materials 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000006959 Williamson synthesis reaction Methods 0.000 description 1
- MZLTWBHTTDHCAV-UHFFFAOYSA-N [2,3-dicyano-4-(trifluoromethylsulfonyloxy)naphthalen-1-yl] trifluoromethanesulfonate Chemical compound C1=CC=C2C(OS(=O)(=O)C(F)(F)F)=C(C#N)C(C#N)=C(OS(=O)(=O)C(F)(F)F)C2=C1 MZLTWBHTTDHCAV-UHFFFAOYSA-N 0.000 description 1
- PZRPBPMLSSNFOM-UHFFFAOYSA-N [4-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=C(B(O)O)C=C1 PZRPBPMLSSNFOM-UHFFFAOYSA-N 0.000 description 1
- YDPVAYXEHNRIKW-UHFFFAOYSA-M [Br-].ClCCCC[Zn+] Chemical compound [Br-].ClCCCC[Zn+] YDPVAYXEHNRIKW-UHFFFAOYSA-M 0.000 description 1
- CKCYDFVZAPRMBQ-UHFFFAOYSA-M [Cl-].CCCCCCCCCC[Mg+] Chemical compound [Cl-].CCCCCCCCCC[Mg+] CKCYDFVZAPRMBQ-UHFFFAOYSA-M 0.000 description 1
- IYRNUFOFIFCJLO-UHFFFAOYSA-M [Cl-].CCCCCCCCCC[Zn+] Chemical compound [Cl-].CCCCCCCCCC[Zn+] IYRNUFOFIFCJLO-UHFFFAOYSA-M 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000011374 additional therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 1
- 238000003236 bicinchoninic acid assay Methods 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229920005556 chlorobutyl Polymers 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ALKZAGKDWUSJED-UHFFFAOYSA-N dinuclear copper ion Chemical compound [Cu].[Cu] ALKZAGKDWUSJED-UHFFFAOYSA-N 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- GSFZBNQNAIJHGO-UHFFFAOYSA-N ethyl 4-[2,3-dicyano-4-(4-ethoxy-4-oxobutyl)phenyl]butanoate Chemical compound CCOC(=O)CCCC1=CC=C(CCCC(=O)OCC)C(C#N)=C1C#N GSFZBNQNAIJHGO-UHFFFAOYSA-N 0.000 description 1
- FMVJYQGSRWVMQV-UHFFFAOYSA-N ethyl propiolate Chemical compound CCOC(=O)C#C FMVJYQGSRWVMQV-UHFFFAOYSA-N 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000003041 laboratory chemical Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920003240 metallophthalocyanine polymer Polymers 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 239000002032 methanolic fraction Substances 0.000 description 1
- WJYBMWHJTZBYSO-UHFFFAOYSA-N methyl 3-bromobutanoate Chemical compound COC(=O)CC(C)Br WJYBMWHJTZBYSO-UHFFFAOYSA-N 0.000 description 1
- MWZPENIJLUWBSY-VIFPVBQESA-N methyl L-tyrosinate Chemical compound COC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWZPENIJLUWBSY-VIFPVBQESA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- HQFYIDOMCULPIW-UHFFFAOYSA-N n-methylprop-2-yn-1-amine Chemical compound CNCC#C HQFYIDOMCULPIW-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- 229940078487 nickel acetate tetrahydrate Drugs 0.000 description 1
- OINIXPNQKAZCRL-UHFFFAOYSA-L nickel(2+);diacetate;tetrahydrate Chemical compound O.O.O.O.[Ni+2].CC([O-])=O.CC([O-])=O OINIXPNQKAZCRL-UHFFFAOYSA-L 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000005151 nonafluorobutanesulfonyl group Chemical group FC(C(C(S(=O)(=O)*)(F)F)(F)F)(C(F)(F)F)F 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 238000001907 polarising light microscopy Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- INGJYKISFRSCQV-UHFFFAOYSA-N tert-butyl-(4-iodobutoxy)-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCCCCI INGJYKISFRSCQV-UHFFFAOYSA-N 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UMHFSEWKWORSLP-UHFFFAOYSA-N thiophene 1,1-dioxide Chemical compound O=S1(=O)C=CC=C1 UMHFSEWKWORSLP-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000006478 transmetalation reaction Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- YEMJHNYABQHWHL-UHFFFAOYSA-N tributyl(ethynyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C#C YEMJHNYABQHWHL-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
- C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
- C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
- C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Mathematical Physics (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Theoretical Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929064.5A GB9929064D0 (en) | 1999-12-08 | 1999-12-08 | Substituted phthalocyanines and their precursors |
| GB0012348A GB0012348D0 (en) | 1999-12-08 | 2000-05-22 | Substituted phthalocyanines and their precursors |
| GBGB0025817.8A GB0025817D0 (en) | 1999-12-08 | 2000-10-20 | Substituted phthalocyanines and their precursors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20021974A3 true CZ20021974A3 (cs) | 2002-11-13 |
Family
ID=27255732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20021974A CZ20021974A3 (cs) | 1999-12-08 | 2000-12-08 | Substituované ftalocyaniny, způsob jejich výroby a farmaceutický prostředek obsahující tyto sloučeniny |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1238016A1 (no) |
| JP (1) | JP2003516421A (no) |
| AU (1) | AU2192201A (no) |
| CA (1) | CA2394891A1 (no) |
| CZ (1) | CZ20021974A3 (no) |
| EE (1) | EE200200298A (no) |
| HU (1) | HUP0301099A3 (no) |
| NO (1) | NO20022663L (no) |
| PL (1) | PL355851A1 (no) |
| WO (1) | WO2001042368A1 (no) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2441386C (en) * | 2001-03-21 | 2010-12-21 | L. Molteni E C. Dei Fratelli Alitti Societa Di Esercizio S.P.A. | Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| EP1346971B1 (en) | 2002-03-18 | 2010-01-20 | Sumitomo Chemical Company, Limited | Production method for biarylalanine |
| CN100415715C (zh) * | 2003-02-11 | 2008-09-03 | 杜锡光 | 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途 |
| CA2525447C (en) | 2003-05-14 | 2013-08-06 | Universite De Sherbrooke | Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| JP4809657B2 (ja) * | 2005-09-29 | 2011-11-09 | 富士フイルム株式会社 | ナフタロシアニン色素およびその製造方法 |
| JP4942351B2 (ja) * | 2006-01-31 | 2012-05-30 | 独立行政法人科学技術振興機構 | 光線力学治療抗癌剤 |
| JP5296355B2 (ja) * | 2007-09-11 | 2013-09-25 | 株式会社日本触媒 | アリール基含有フタロシアニン化合物、その製造方法、及び、配合物 |
| US8168359B2 (en) * | 2008-03-10 | 2012-05-01 | Xerox Corporation | Nanosized particles of phthalocyanine pigments |
| CZ303612B6 (cs) * | 2010-08-19 | 2013-01-09 | Výzkumný ústav organických syntéz a.s. | Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny |
| JP2012167189A (ja) * | 2011-02-14 | 2012-09-06 | Aisin Seiki Co Ltd | フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池 |
| JP2013193956A (ja) * | 2012-03-15 | 2013-09-30 | Saitama Univ | tetrakis−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法 |
| JP6278386B2 (ja) * | 2013-11-06 | 2018-02-14 | 国立研究開発法人産業技術総合研究所 | フタロシアニン化合物及び有機半導体材料 |
| CN103864645B (zh) * | 2013-12-30 | 2016-08-17 | 常州大学 | 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法 |
| CN104016995A (zh) * | 2014-06-26 | 2014-09-03 | 常州大学 | 八取代全氟烷基钴酞菁化合物及其制备方法 |
| JP6608187B2 (ja) * | 2015-06-22 | 2019-11-20 | 山本化成株式会社 | 増感色素、半導体電極、光電変換素子および色素増感太陽電池 |
| KR102207689B1 (ko) | 2016-08-24 | 2021-01-25 | 시노라 게엠베하 | 유기 분자, 특히 유기 광전자 디바이스에 사용하기 위한 유기 분자 |
| CN108017650A (zh) * | 2017-03-08 | 2018-05-11 | 先尼科化工(上海)有限公司 | 一种用于滤光片的酞菁化合物及其制备方法和应用方法 |
| JP6922361B2 (ja) * | 2017-04-07 | 2021-08-18 | Jsr株式会社 | 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子 |
| US11015061B2 (en) | 2017-04-07 | 2021-05-25 | Yamamoto Chemicals, Inc. | Phthalocyanine-based compound and uses of same |
| EP3611175B1 (en) * | 2017-04-07 | 2022-02-09 | Yamamoto Chemicals, Inc. | Naphthalocyanine compound, method for producing same, and use thereof |
| JP7431744B2 (ja) * | 2018-10-05 | 2024-02-15 | 山本化成株式会社 | フタロシアニン系化合物、及びその用途 |
| CN112279856B (zh) * | 2019-07-24 | 2021-09-17 | 南方科技大学 | 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池 |
| CN112014383B (zh) * | 2020-06-30 | 2024-03-29 | 杜旭忠 | 一种用于均相化学发光的光敏剂及其制备方法和应用 |
| JP7721536B2 (ja) * | 2020-07-31 | 2025-08-12 | 住友化学株式会社 | 化合物 |
| CN112812299B (zh) * | 2020-12-31 | 2022-03-29 | 四川大学 | 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法 |
| WO2022196089A1 (ja) * | 2021-03-15 | 2022-09-22 | ソニーグループ株式会社 | リポソーム複合体、物質送達システム、物質送達方法及び光照射装置 |
| EP4574911A1 (en) | 2023-12-22 | 2025-06-25 | Holland Colours N. V. | Bio-sourced phthalocyanine complex, preparation and use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3576823D1 (de) * | 1984-03-21 | 1990-05-03 | Ici Plc | Infrarot-absorber. |
| GB8431446D0 (en) * | 1984-12-13 | 1985-01-23 | Secr Defence | Alkoxyphthalocyanines |
| GB8619238D0 (en) * | 1986-08-06 | 1986-09-17 | Ici Plc | Organic photoconductor |
| ATE79644T1 (de) * | 1987-02-13 | 1992-09-15 | Secr Defence Brit | Substituierte phthalocyanine. |
| JPH0730300B2 (ja) * | 1988-04-01 | 1995-04-05 | 三井東圧化学株式会社 | アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料 |
| DE68928559T2 (de) * | 1988-12-15 | 1998-06-18 | Mitsui Toatsu Chemicals | Absorbiermittel im nahen Infrarot und Anzeige-/Aufzeichnungsmaterialien, die daraus hergestellt sind |
| JPH07103093B2 (ja) * | 1989-01-12 | 1995-11-08 | 三井東圧化学株式会社 | フタロニトリル系化合物およびその製造方法 |
| DE69228502T2 (de) * | 1991-06-19 | 1999-08-12 | Mitsui Chemicals, Inc., Tokio/Tokyo | Phthalocyaninverbindungen und ihre Verwendung |
| EP0700961B1 (en) * | 1991-11-08 | 1998-12-23 | Eastman Chemical Company | Thermoplastic polymer composition having admixed therein one or more monomeric near-infrared fluorescing compounds |
| GB9317881D0 (en) * | 1993-08-27 | 1993-10-13 | Secr Defence | Photosensitizers |
| US5456998A (en) * | 1994-04-26 | 1995-10-10 | Xerox Corporation | Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers |
| JPH0892190A (ja) * | 1994-09-26 | 1996-04-09 | Kanto Chem Co Inc | シアノビフェニル誘導体並びにそれらを含む液晶組成物 |
| GB9613476D0 (en) * | 1996-06-27 | 1996-08-28 | British Polythene Ltd | Improvements in or relating to films and/or coatings |
| IT1294325B1 (it) * | 1997-08-14 | 1999-03-24 | Molteni L E C Dei Fratelli Ali | Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici |
| WO2000021965A1 (en) * | 1998-10-13 | 2000-04-20 | Brown University Research Foundation | Substituted perhalogenated phthalocyanines |
-
2000
- 2000-12-08 EE EEP200200298A patent/EE200200298A/xx unknown
- 2000-12-08 CA CA002394891A patent/CA2394891A1/en not_active Abandoned
- 2000-12-08 HU HU0301099A patent/HUP0301099A3/hu unknown
- 2000-12-08 CZ CZ20021974A patent/CZ20021974A3/cs unknown
- 2000-12-08 JP JP2001543656A patent/JP2003516421A/ja active Pending
- 2000-12-08 WO PCT/GB2000/004708 patent/WO2001042368A1/en not_active Ceased
- 2000-12-08 PL PL00355851A patent/PL355851A1/xx not_active Application Discontinuation
- 2000-12-08 EP EP00985506A patent/EP1238016A1/en not_active Withdrawn
- 2000-12-08 AU AU21922/01A patent/AU2192201A/en not_active Abandoned
-
2002
- 2002-06-05 NO NO20022663A patent/NO20022663L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022663L (no) | 2002-08-08 |
| EE200200298A (et) | 2003-08-15 |
| WO2001042368A1 (en) | 2001-06-14 |
| AU2192201A (en) | 2001-06-18 |
| NO20022663D0 (no) | 2002-06-05 |
| CA2394891A1 (en) | 2001-06-14 |
| JP2003516421A (ja) | 2003-05-13 |
| HUP0301099A2 (hu) | 2003-08-28 |
| EP1238016A1 (en) | 2002-09-11 |
| PL355851A1 (en) | 2004-05-31 |
| HUP0301099A3 (en) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20021974A3 (cs) | Substituované ftalocyaniny, způsob jejich výroby a farmaceutický prostředek obsahující tyto sloučeniny | |
| AU664377B2 (en) | Porphycene compounds for photodynamic therapy | |
| Roeder et al. | Photophysical properties and photodynamic activity in vivo of some tetrapyrroles | |
| Ruzié et al. | Tailoring a bacteriochlorin building block with cationic, amphipathic, or lipophilic substituents | |
| US5409900A (en) | Porphycene compounds for photodynamic therapy | |
| HU221102B1 (en) | Beta,beta'-dihydroxy meso-substituted chlorins, bacteriochlorins, isobacteriochlorins, and process for preparing thereof | |
| KR100358273B1 (ko) | 광감작제 | |
| AU700299B2 (en) | Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same | |
| Woehrle et al. | Synthesis and photochemical properties of phthalocyanine zinc (II) complexes containing o-carborane units | |
| Babu et al. | Synthesis, characterization and photodynamic activity of Sn (IV) triarylcorroles with red-shifted Q bands | |
| WO2002096913A1 (en) | Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses | |
| KR102345008B1 (ko) | 화합물, 상기 화합물을 포함하는 조성물, 및 상기 조성물을 이용하여 종양 세포를 비활성화 또는 사멸시키는 광역학 치료방법 | |
| CN113831351B (zh) | 一类新型四吡咯衍生物及其应用 | |
| JP6781710B2 (ja) | ハロゲン化テトラフェニルバクテリオクロリンおよびクロリンのアトロプ異性体、並びに光線力学療法におけるその使用 | |
| Li et al. | Cobaltacarborane–phthalocyanine conjugates: Syntheses and photophysical properties | |
| CN109456352A (zh) | 苯硼酸酯修饰的过氧化氢可激活式氟硼二吡咯光敏剂及其制备 | |
| Luguya et al. | Synthesis and cellular studies of a carboranylchlorin for the PDT and BNCT of tumors | |
| CN116606313B (zh) | 一种基于Aza-BODIPY的高亮度NIR-II区光热剂及制备方法及应用 | |
| CN114409687B (zh) | 一种可在肿瘤内切换光治疗模式的光敏药物及其制备方法和应用 | |
| AU2004220406B2 (en) | Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof | |
| Peng et al. | Synthesis, separation and characterization of amphiphilic 2, 10-di-sulfonato-18, 26-di-phthalimidomethyl phthalocyanine zinc di-potassium salt by template reaction | |
| US20230129899A1 (en) | Compound, photosensitizer comprising same, composition for diagnosing or treating tumor targeting mitochondria, and photodynamic treatment method using composition | |
| CA2399217A1 (en) | Porphyrins and related compounds | |
| RU2789401C1 (ru) | КАРБОРАНОВЫЕ ПРОИЗВОДНЫЕ 4,4-ДИФТОР-4-БОРА-3а,4а-ДИАЗА-s-ИНДАЦЕНА, ПРОЯВЛЯЮЩИЕ ПРОТИВООПУХОЛЕВУЮ АКТИВНОСТЬ | |
| RU2551539C2 (ru) | Способ получения борированных порфиринов |